Monte Rosa Therapeutics, Inc. (GLUE)

16.46 +0.14 (+0.89%) USD  |  NASDAQ  |  Dec 15, 16:00
16.28 -0.18 (-1.06%) After-Hours: 19:22
More

Monte Rosa Therapeutics Cash and Short Term Investments (Quarterly): 391.26M for Sept. 30, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Novartis AG 9.753B
AVITA Medical, Inc. 23.31M
ENvue Medical, Inc. 6.98M
Mirum Pharmaceuticals, Inc. 375.55M
Day One Biopharmaceuticals, Inc. 451.58M